Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients 12 years of age and older with a 2 year history of moderate to severe seasonal allergic rhinitis~* Must be in generally good health~* Must meet minimum symptom requirements, as specified in the protocol~* Must be wiling and able to provide informed consent and to participate all study procedures~* Positive skin test to a prevalent spring allergen~Exclusion criteria:~* On nasal examination,the presence of nasal mucosal erosion, nasal ulceration or nasal septal perforation~* Nasal disease likely to affect the deposition of the medication or evaluation, such as sinus infection, nasal polyps or severe deviated septum~* Nasal or sinus surgery within the previous 6 months~* Chronic sinus infection (more than 3 per year)~* Planned travel outside the study area during the study period~* Use of any investigational drug within 30 days of the first visit~* Hypersensitivity (bad reaction) to azelastine hydrchloride nasal spray (Astelin), or fluticasone propionate nasal spray (Flonase)~* Women who are not using an acceptable method or birth control~* Women who are pregnant or nursing~* Upper respiratory tract infection such as common cold, flu, sinus infection within 2 weeks of first study visit~* Asthma or other lung diseases such as COPD. Mild asthma symptoms may be considered after consultation with the investigator~* Irregular heartbeat or other symptomatic heart conditions~* History of alcohol or drug abuse~* History of glaucoma~* Use of medications that could affect the study results

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- fluticasone propionate (Type: ACTIVE_COMPARATOR): None
- azelastineHcl/fluticasone propionate (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None
- azelastine Hcl (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).